A Phase I Clinical Trial of Oral Calcitriol with Fixed Dose of Cisplatin and Gemcitabine in Patients with Advanced Solid Tumors
Description: 

To determine the maximum tolerated dose of oral calcitriol when combined with a standard dose of gemcitabine and cisplatin in a 28-day cycle. Secondary Objective: Describe the toxicity of this combination using CTCAE version 4.0. Study the pharmacokinetics of calcitriol at the MTD in an expanded cohort of 6 patients. Describe the clinical activity associated with this regimen in this advanced solid tumor population.

Study Number: 

I 163509

Phase: 
I
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01093092

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.